Trial Profile

A Combined Phase I & II Trial of Intravesicular Abraxane, a Nanoparticle Albumin-Bound Paclitaxel, for Treatment-Refractory Transitional Cell Carcinoma of the Urinary Bladder.

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 24 Feb 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

17 Feb 2025 The protocol has been amended to change in Interventional Study Model, and primary endpoints and other parameters.
17 Feb 2025 Status changed from recruiting to completed.
05 Nov 2012 Planned end date changed from 1 Jul 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com